ALS Update: Drug Therapy Continues to Offer Little BenefitOctober 21, 2024Neuromuscular DisordersRare Diseases
Myasthenia Gravis: Similar Symptoms in Relatives Raise Question of GenesOctober 18, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
At Last, Treatment Is in Sight for Charcot-Marie-Tooth DiseaseOctober 17, 2024Neuromuscular DisordersRare Diseases
Sustained Control with Investigational Monoclonal Antibody for Myasthenia GravisOctober 17, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
First-in-Class B-Cell Depleting Agent Promising for Myasthenia GravisOctober 17, 2024Myasthenia GravisNeuromuscular DisordersRare Diseases
Balancing Act: Weighing the Pros and Cons of Genetic Testing in Rare DiseasesSeptember 30, 2024Rare DiseasesGene Therapy
Myasthenia Gravis: Patient Choice, Cultural ChangeSeptember 30, 2024Rare DiseasesMyasthenia GravisNeuromuscular Disorders
Neuromyelitis Optica: Historically Misdiagnosed — Now Demands Prompt TreatmentSeptember 30, 2024Rare Diseases
Diagnosing and Managing Duchenne Muscular Dystrophy: Tips for Practicing CliniciansSeptember 30, 2024Rare DiseasesPediatricsNeuromuscular Disorders
Promise for Disease-Modifying Therapies to Tame Huntington’s DiseaseSeptember 30, 2024Rare DiseasesNeuromuscular Disorders
Newborn Screening Programs: What Do Clinicians Need to Know?September 30, 2024Rare DiseasesNeurodevelopmental DisordersPediatrics
Genetic Testing for ALS, Now a Standard, Creates a Path Toward Individualized CareSeptember 25, 2024Rare DiseasesNeuromuscular Disorders
